chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on chest, stomach and entire back.; This is a spontaneous report from a contactable other hcp (patient). A non-pregnant 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date were not reported), via an unspecified route of administration, administered in the right arm on 26Feb2021 07:00 (at the age of 48-years-old), as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medication included levothyroxine sodium (LEVOXYL) taken for an unspecified indication, start and stop date were not reported. The patient previously took cefalexin (KEFLEX) and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on chest, stomach and entire back on 28Feb2021 03:00. No treatment was received as a result of the event. The event also did not result to either emergency room or physician office visit. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema
Clinical narrative: Round blister shallow crates mildly erythematous about 2xm; Round blister shallow crates mildly erythematous about 2xm; This is a spontaneous report from a contactable consumer. A 90-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 15Feb2021 at 14:00 (at the age of 90-years-old) (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure, heart valves, pre atrial contractions, and atrial fibrillation. The patient was not pregnant at the time of the events. The patient has no known allergies. Concomitant medications included metoprolol succinate (TOPROL), ranolazine (RANEXA), paracetamol (TYLENOL), metoprolol tartrate (LOPRESSOR) and calcium (CALCIUM). The patient did not receive other vaccines in four weeks. Toprol, Ranexa, Tylenol, Lopressor, and calcium were received in two weeks. The patient did not have COVID prior to vaccination and had not been tested for COVID post-vaccination.  On 16Feb2021, the patient experienced round blister shallow crates mildly erythematous about 2xm. No treatment was received for the events. The outcome of the events was not recovered/not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pruritus
Clinical narrative: Itching all over body; nausea; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6198), via an unspecified route of administration, administered in the left arm on 26Feb2021, at 10:45 (at the age of 70 years old) as dose 1, single for COVID-19 immunisation. Medical history included pacemaker, SVT, and known allergies. The patient was not pregnant, and she was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included heart meds, vitamins, and diphenhydramine hydrochloride (BENADRYL). She did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Feb2021, the patient experienced itching all over body and nausea. She has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of itching all over body and nausea. The patient was recovering from the events at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: very itchy rash; This is a spontaneous report from a contactable consumer (patient) received. A non-pregnant 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL9267 and Expiration date: not reported) via an unspecified route of administration, administered on the left arm on 12Feb2021 14:00 (at the age of 45 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history included depression. The patient had no known allergies. Concomitant medications included fluoxetine hydrochloride (PROZAC), calcium, ashwagandha, cyanocobalamin (B12), and ascorbic acid;betacarotene;biotin;calcium;chromium;colecalciferol;copper;folic acid;iodine;iron;lycopene;magnesium;manganese;nicotinamide;pantothenic acid;phosphorus;phytomenadione;potassium;pyridoxine hydrochloride;retinol;riboflavin;selenium;vitamin b1 nos;vitamin b12 nos;vitamin e nos;xantofyl;zinc (CENTRUM SILVER) taken for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 13Feb2021, the patient developed a very itchy rash. The rash started on the arm where the injection was and spread under the arm into the armpit area, around the chest area, and onto the other upper arm and armpit area. The patient used hydrocortisone (CORTIZONE, cream) and calamine as treatment. The patient recovered from the event on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoptysis
Clinical narrative: phlegm had blood within; This is a spontaneous report from a contactable consumer (patient) via Pfizer sales representative. A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported), via an unspecified route of administration on 19Feb2021 10:15 AM (at the age of 67-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included acetylsalicylic acid (ASPIRIN) taken for an unspecified indication; start and stop dates were not reported. The patient previously took clarithromycin (KETEK) and experienced allergy. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient experienced phlegm had blood within on 20Feb2021 08:00AM, the morning after first vaccine. No treatment was taken for the events. The outcome of the event was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: body aches; headache; fever; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (Age: 51, Unit: Unknown) received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter's wife received first dose of vaccine yesterday, 27Feb2021 and last night she started having body aches, she still have now body aches and a strong headache and she has a bit of a fever 99.4 (unit unknown).  Patient was experiencing the following symptoms today (28Feb2021): headache, having body aches, fever of 99.4. Reporter would like to know if it is okay for his wife to take Tylenol. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash papular
Clinical narrative: Started with little red bumps that itched; lower right arm had a rash from elbow to wrist; This is a spontaneous report from a contactable consumer (patient) received via a regulatory authority. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),via an unspecified route of administration, administered in right arm on 09Feb2021 at 10:30 (Batch/Lot Number: EM9810) (at the age of 69-years-old) as dose 1, single for COVID-19 immunisation. Medical history included diabetic and known allergies to Penicillin, Sulfa and Codeine. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination.  Concomitant medications included atorvastatin; glipizide; insulin degludec (TRESIBA) and Vitamin D; all taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient experienced started with little red bumps that itched then lower right arm had a rash from elbow to wrist on 16Feb2021 at 09:00. The patient received no treatment for the events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pyrexia
Clinical narrative: Achy; Feverish; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL 9267, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 26Feb2021 at 15:30 (at the age of 67-years-old)  as dose 1, single for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient's concomitant medications were not reported. On 27Feb2021 at 16:45, the patient experienced achy, feverish, and joint pain. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.   No follow-up attempts are possible. No further information expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itchiness on the body; rash; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: 9262), via an unspecified route of administration in right arm on 15Feb2021 at 12:00, age at vaccination was 69-year-old, as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and post vaccination, the patient has not been tested for COVID-19. The patient's historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL9262) via an unspecified route of administration in right arm on 24Jan2021 at 12:00 as dose 1, single for COVID-19 immunization. On 25Feb2021, the patient experienced itchiness on the body and rash. No therapeutic measures were taken as a result of the events. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching and rash; Itching and rash; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EM9809), via an unspecified route of administration, administered in arm left on 19Feb2021 12:00 (at the age of 81-years-old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccine was administered at the clinic. The patient had no known medical history. There were no concomitant medications. On 26Feb2021 12:00, the patient experienced itching and rash. No treatment was received for the events. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Pain in extremity
Clinical narrative: Bruising on my arm and soreness.; Mild headache; Bruising on my arm and soreness.; This is a spontaneous report from a contactable other healthcare professional (patient). A 25-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: EN6500), dose 1 via an unspecified route of administration, administered in left arm on 24Feb2021 18:45 (at the age of 25-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No other vaccine in four weeks. On 25Feb2021 at 07:00, the patient experienced bruising on her arm and soreness and mild headache the day after injection. No Covid prior vaccination nor tested with Covid post vaccination. The patient received no treatment for the events. The patient recovered from the events on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Malaise
Clinical narrative: he "doesn't feel well"; feeling flushed; This is a spontaneous report from a Pfizer sponsored programs and regulatory authority Support. A contactable consumer (patient) reported that a 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 for COVID-19 immunisation on an unspecified date. The patient's medical history was not reported. Concomitant medication included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. It was reported that the patient "doesn't feel well" and is "feeling flushed". He explained he took a Tylenol and asked if it is ok to take such medication post vaccination. The outcome of the events was unknown.    Follow-up attempts are completed. No further information is expected.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on legs; This is a spontaneous report from a contactable consumer (patient) received via Pfizer study. An 84-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in right arm, on 05Feb2021 at 01:00 PM (Batch/Lot Number: EL342Z) (at the age of 83 years old) as dose 1, single for COVID-19 immunisation. Medical history included diabetic and chronic obstructive pulmonary disease (COPD). The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on legs on an unspecified date in Feb2021 after receiving the first dose. The patient was administered the second dose of BNT162B2 on 26Feb2021, single (at the age of 84-years-old) (Batch/Lot Number: EN62NZ) in the right arm for COVID-19 immunisation and experienced rash on the arm and rash on the legs on 26Feb2021. The patient has not taken any treatment for the event. The patient did not recover from the event on the time of the report.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Myalgia, Neck pain, Pain in extremity
Clinical narrative: Sore arm; sore neck; sore back; sore muscles; Fever of 99.9; This is a spontaneous report from a contactable healthcare professional (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscularly, administered in left arm, on 26Feb2021 at 02:45 PM (Batch/Lot Number: EN6198) (at the age of 57 years old) as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism, high blood pressure, and COVID-19. The patient has no known allergies. The patient was not pregnant at the time of vaccination. The patient was concomitantly taking unspecified medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sore arm, sore neck, sore back and muscles and fever of 99.9 on 27Feb2021 at 06:00 AM. The patient underwent lab tests and procedures which included fever: 99.9, on 27Feb2021. The patient has not been tested for COVID-19 since the vaccination. The patient has not taken any treatment for the events. The patient did not recover from the events on the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sore arm; sore neck; sore back; sore muscles; Fever of 99.9; This is a spontaneous report from a contactable healthcare professional (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscularly, administered in left arm, on 26Feb2021 at 02:45 PM (Batch/Lot Number: EN6198) (at the age of 57 years old) as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism, high blood pressure, and COVID-19. The patient has no known allergies. The patient was not pregnant at the time of vaccination. The patient was concomitantly taking unspecified medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sore arm, sore neck, sore back and muscles and fever of 99.9 on 27Feb2021 at 06:00 AM. The patient underwent lab tests and procedures which included fever: 99.9, on 27Feb2021. The patient has not been tested for COVID-19 since the vaccination. The patient has not taken any treatment for the events. The patient did not recover from the events on the time of the report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Gait disturbance
Clinical narrative: getting pain in hip; became very, very painful; very bad lower back pain; She could hardly walk; This is a spontaneous report from a contactable consumer. An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Feb2021 (Lot Number: EN6200) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. Medical history included Alzheimer's from an unknown date. The patient's concomitant medications were not reported. The reporter (patient's husband) stated, "I am calling about the Pfizer's COVID shot. About six hours after she received the shot yesterday, there are a couple of things. She is 83. She has Alzheimer's. She received the shot yesterday, about six hours later she started getting this pain in her hip. And it became very, very painful. And I am just wondering if that could be from the shot?" The patient got very bad lower back pain. She could hardly walk. Events occurred in Feb2021. The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Tongue discomfort
Clinical narrative: Tongue swelled up; Tongue was burning; This is a spontaneous report from a contactable pharmacist (patient). A non-pregnant 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 26Feb2021 at 21:00 (Lot Number: En6205, unknown expiration; at the age of 35 years old) as dose 1, single for COVID-19 immunisation.  The patient medical history was not reported. Concomitant medication included escitalopram. No known allergies. No other vaccine in four weeks. The patient's tongue was burning, and tongue swelled up on 28Feb2021 at 10:00 am. The patient did not receive treatment for the events.  The patient has no COVID prior vaccination and has not been tested for COVID post vaccination. The patient is recovering from the events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Ocular hyperaemia
Clinical narrative: Headache; Will that cause your eye, your eyes could turn color, it's sort of red, it's reddish/ My eyes are all of sudden red; This is a spontaneous report from a contactable consumer (patient). An 85-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 20Feb2021 (Batch/Lot Number: EL9261) as dose 2, single (at the age of 85-years-old) for Covid-19 immunisation. Medical history included blood pressure abnormal. Concomitant medication included blood pressure pills. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration in Jan2021 (Batch/Lot Number: unknown) as dose 1, single for Covid-19 immunisation. The patient had his second shot on last Saturday (20Feb2021), and the only effect he was feeling was headache on an unspecified date, which he knew he was going to get. The patient then asked if the vaccine would cause the eye to turn color, it was sort of red, it was reddish, and asked if that would be a side effect. The patient had the first dose three weeks prior (Jan2021). Regarding the treatment in response to the event, the patient stated no, he wears glasses but (incomplete sentence). The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Fatigue; chills; low grade fever (99 degrees F); This is a spontaneous report from a non-contactable consumer (patient).   A 53-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Left Arm on 25Feb2021 11:15, at the age of 53-years-old, (Lot Number: EL9267) as DOSE 2, SINGLE for covid-19 immunisation. The patient is not pregnant at the time of vaccination. The patient medical history was reported as none. The patient did not have COVID-19 prior vaccination. Historical vaccine includes dose 1 of BNT162B2, Lot number: EM9810, on 04Feb2021, 11:15 AM at Left arm. Concomitant medications included paracetamol (TYLENOL); ibuprofen; vitamin d3; pseudoephedrine hydrochloride (SUDAFED); and ascorbic acid (VITAMIN C ACID), all were taken for unspecified indication, start and stop date were not reported.  On 26Feb2021 15:00, the patient experienced fatigue, chills, and low grade fever (99 degrees F).  The patient underwent lab tests and procedures which included body temperature: 99 degrees F.  The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovering. No treatment was received for the events.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Vaccination site pain
Clinical narrative: injection site sore; headache; joint pain; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 (at the age of 57-years-old) (Batch/Lot Number: EN5318) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included penicillin (allergy). The patient did not have COVID prior vaccination. The patient received first dose of BNT162B2 on 02Feb2021 at the age of 57-years-old for COVID-19 immunization (dose number=1, BioNTech, lot number =EN5318, administration date=02Feb2021, administration time=13:30 PM, vaccine location=Right arm). On 23Feb2021 23:45, the patient experienced injection site sore, headache, joint pain. Therapeutic measures were taken as a result of injection site sore, headache, arthralgia: Tylenols were taken. The outcome of the events was recovered. The patient was not covid tested post vaccination.   No follow-up attempts are possible. No further information is expected
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Eye pruritus, Hypersensitivity, Nasal congestion, Sneezing
Clinical narrative: slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported),via an unspecified route of administration, administered in left arm on 22Jan2021 at 10:15 (at the age of 42 years old) as dose 1, single for COVID-19 immunisation in a Pharmacy or Drug Store. Medical history included asthma, ITP (immune thrombocytopenic purpura), autoimmune neutropenia, allergies to animal dander, dust, sulfa and kiwi - all from an unknown date. The patient previously given ceftriaxone (ROCEFIN) and ciprofloxacin and experienced allergy. The patient was not pregnant at time of vaccination and prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines in 4 weeks prior to the COVID vaccine. The patient has a list of other medications received in 2 weeks of vaccination. On 25Jan2021, the patient experienced slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes) 2 days after vaccine was given. The adverse events resulted to Doctor or other healthcare professional office/clinic visit. Treatment was given as response to the events which included unspecified allergy eye drops and inhaler. Since vaccination, the patient has not been tested for COVID-19. Outcome of all events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid rash, Eyelids pruritus, Feeling abnormal, Skin swelling, Urticaria
Clinical narrative: eyelid was itching; skin on the side of my eye was puffy/swollen; tiny hive above the eyelid; white rash just above the eyelid; 3-4 minutes after the shot my left eye felt "funny", right in the corner by the tear duct; This is a spontaneous report from a contactable consumer (patient) received via  portal. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 25Feb2021 at 12:30 (Batch/Lot Number: EN6200) (at the age of 69-years-old) as dose 1, single for COVID-19 immunisation. Medical history included stroke on 2014; known allergies to Iodine Dye (allergic reaction to a contrast x-ray, where left eye "felt funny" and then face swelled up), Erythromycin, Sulphur Drugs, and surgical tape. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medications included apixaban (ELIQUIS); propranolol; ezetimibe; zolpidem; ergocalciferol (VIT D) and B12 (CYANOCOBALAMIN); all taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient experienced 3-4 minutes after the shot her left eye felt "funny", right in the corner by the tear duct on 25Feb2021; eyelid was itching and looking at her magnetized mirror the skin on the side of her eye was puffy/swollen just by the nose and it looked like a tiny hive or tiny white rash just above the eyelid where it was itching on 25Feb2021 at 12:30. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia, Ear discomfort, Rash
Clinical narrative: Hot/burning ears; Rash neck, chest, and back; Sour stomach; This is a spontaneous report from a non-contactable consumer (patient). A 41-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number was not reported), via an unspecified route of administration on 26Feb2021 13:00 (at the age of 41-years-old) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks of the COVID-19 vaccine. Prior to vaccination, the patient did not have COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Feb2021, the patient experienced hot/burning ears, rash in neck, chest, and back, and sour stomach. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This is a spontaneous report from a non-contactable other healthcare professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via an unspecified route of administration on Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown if patient had covid prior to vaccination. It was unknown if other vaccines were given in four weeks prior to vaccination. On an unspecified date on Feb2021, the patient experienced rash that occurred a few days after receiving the vaccine which resulted in emergency room visit. The patient took steroid cream as treatment for the event. It was unknown if patient tested for covid post vaccination. Outcome rash was unknown.    No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Lymphadenopathy, Rash
Clinical narrative: Swelling in lymph node of left arm; Rash on neck and face; Little pimple like bumps; This is a spontaneous report from a non-contactable consumer (patient).  A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 25Feb2021 09:30 (lot number: EL9262; expiry date: unknown) at the age of 46-years-old, as dose 2, single, for Covid-19 immunisation. Medical history included Colitis and Hashimoto's. The patient had no known allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC R); mesalazine (APRISO); and doxycycline taken for unspecified indications, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Feb2021 at 10:00 AM (lot number: EL9264; expiry date: unknown) in left arm, at the age of 46-years-old, as dose 1, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient was not diagnosed with COVID prior vaccination. The patient has not been tested for COVID-19 since vaccination. On 27Feb2021, the patient experienced rash on neck and face, little pimple like bumps and swelling in lymph node of left arm. The patient did not receive treatment for the events. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Vaccination site bruising
Clinical narrative: Experiencing sore arm; muscle pain; bruise at the injection site; This is a spontaneous report from a contactable consumer (patient) via a Pfizer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sore arm, muscle pain and bruise at the injection site. The patient wanted to now if she could take ibuprofen as she knew that she cannot take Tylenol after her second dose of the vaccine. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Investigation, Suspected COVID-19
Clinical narrative: cough; her husband was diagnosed with Covid and she has had a test (2021) she is in quarantine until the 7th; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 09Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient was not reported. Medical history included her husband was diagnosed with Covid and she is in quarantine (2021). The patient's concomitant medications were not reported. The patient reported that she had cough and her husband was diagnosed with Covid and she has had a test (2021) she is in quarantine until the 7th (suspect covid-19) on an unspecified date in 2021. It was further reported that she had a cough but no fever. The patient added that her husband has had diarrhea and a cough and because he has dementia, she called the ambulance and they put him in the hospital, and he was diagnosed with Covid. He has been there since last Sunday (21Feb2021) and they want to release him today (01Mar2021). She has had a test (2021) but no results yet but she is in quarantine until the 7th (07Mar2021) and they are supposed to get their second vaccine on 05Mar2021. She needs to reschedule her appointment. The outcome of the events was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the right arm on Feb2021 as dose 1, single, with route of administration unspecified, for COVID-19 immunization. The patient had no relevant medical history. The patient's concomitant medications were not reported. On 01Mar2021, the patient had shortness of breath upon getting back in bed and lying down. The outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: A rash 3x5 inch red rash in the left arm about 3 inches below the injection site.; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration, administered in left arm on 24Feb2021 11:15 (at the age of 66-years-old) as dose 2, single for COVID-19 immunization. Medical history included hypertension, cholesterol, and known allergies to latex. Prior to vaccination, the patient was not pregnant, did not have COVID, and did not receive other vaccines within four weeks. Post-vaccination, the patient has not been tested for COVID-19. Concomitant medications included rosuvastatin calcium (CRESTOR); carvedilol (COREG); fish oil; and acetylsalicylic acid (ASPRIN); all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (lot number: EL9269) administered in the left arm on 03Feb2021 12:30 for COVID-19 immunization. The patient experienced a rash 3x5 inch red rash in the left arm about 3 inches below the injection site on 27Feb2021 17:00. No treatment was received for the event. Outcome of the event was recovering.    No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Epicondylitis
Clinical narrative: Joint Pain/right elbow consistent pain/pain in left elbow and both knees/pain in right knee; tennis elbow; This is a spontaneous report from a contactable other health professional (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, administered in the right arm, on 05Jan2021 09:30 (Bath/lot number: EL0140), at age 53 years old, as dose 1, single, for COVID-19 immunisation, at a hospital. The patient was not pregnant at the time of vaccination. Relevant medical history included sinus issues from an unknown date, not reported if ongoing or not, and ongoing menopause from an unknown date. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. There were no concomitant medications in two weeks. The patient did not receive any other vaccines in four weeks. On 06Jan2021, the patient experienced joint pain. It started out primarily with consistent pain in right elbow, and some pain in left elbow and both knees. Then the patient had right elbow pain which has not gone away and consistent pain in right knee. The event resulted to physician's office visit. The patient was told that it could be tennis elbow or menopause symptoms. The patient received unspecified treatment for the events. The patient then received the second dose of PFIZER-BIONTECH COVID-19 VACCINE on 27Jan2021 (Batch/lot number: EL3248), administered in the right arm. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a contactable consumer (patient) reported in response to non-hcp letter sent in cross reference case. A 64-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration on 14Jan2021 (at the age of 64-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included none. Concomitant medications included zinc gluconate (CHELATED ZINC [ZINC GLUCONATE]); colecalciferol (VIT D3), both taken for an unspecified indication from Sep2020 and ongoing; ascorbic acid (VIT C) taken for an unspecified indication from Dec2020 and ongoing. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: E11685; Expiration Date: Mar2021) in left arm on unspecified date at 08:20 hr (at the age of 63-years-old) for covid-19 immunisation and experienced fever (for 7 days, highest 101.7 F), loss of taste (LTD), headache body ache, fatigue, loss of appetite, malaise, covid-19 virus test positive (on 30Dec2020; fine now; admission to hospital due to the event: yes; no treatment received) and chills. The patient experienced sore arm on an unspecified date. Clinical outcome of event was unknown.  Information on lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Psoriasis
Clinical narrative: psoriasis flare ups; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 12Feb2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced psoriasis flare ups on 23Feb2021. She will have the 2nd dose on 05Mar2021 and wanted to know if it is safe for her to have it. The outcome of the event was unknown.     No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Nausea, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, on Feb 28, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced pain in her arms, pain in shoulders and nausea on an unspecified date; with outcome of unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: chills; headache; 101 fever; This is a spontaneous report from a contactable consumer (patient). A 60-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 28Jan2021 at 13:30 (at the age of 60-years-old) as dose 1, single for COVID-19 immunisation. The patient has no relevant medical history. The patient has no known allergies. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. Concomitant medications included lisinopril. On 29Jan2021 at 05:30, the patient experienced chills, headache, and 101 fever. Therapeutic measures were taken as a result of event 101 fever included Ibuprofen. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events chills and headache was unknown while the outcome of the event 101 fever was recovered on 30Jan2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: On going hip pain; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported that a female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced an ongoing hip pain but is not related to the COVID-19 vaccine, considers the possibility of receiving a cortisone injection. The outcome of the event was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the events  arthralgia and suspect drug BNT162B2 cannot be established
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: severe watery diarrhea; This is a spontaneous report from a contactable consumer or other non hcp.   An 84-years-old female Non pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 10:30 (Batch/Lot Number: EN5318) as dose 2, single dose for covid-19 immunisation. Medical history included cardiac disorder. Concomitant medication(s) included atenolol (ATENOLOL); diltiazem (DILTIAZEM) apixaban (ELIQUIS); furosemide (FUROSEMIDE); potassium (POTASSIUM) taken for unspecified indication. The patient previously took Augmentin bambini and experienced drug hypersensitivity, Mutlaq and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm right on 29Jan2021 03:45 PM (Batch/Lot Number was EN5318) as single dose for covid-19 immunisation.The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was Reported that, the patient experienced severe watery diarrhoea on 27Feb2021 12:00 with outcome of recovered. Therapeutic measures were taken as a result of severe watery diarrhoea.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site erythema
Clinical narrative: tiny red spot right where the injection; a tiny bit of itching; little bit of redness where the band aid touched her skin; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (pateint). A 70-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 25Feb2021 (at the age of 70-year-old) as single dose for covid-19 immunisation. Medical history included breast cancer that spread to lymph nodes diagnosed in 2018, removed whole lobe of lung, double mastectomy and allergic to the glue in band aids. Patient reported that she was a two time cancer survivor. She was diagnosed with breast cancer in 2018 that spread to her lymph nodes.  While getting radiation for that, they found an 11 mm spot of cancer in the lower right lobe of her lung. They removed the whole lobe on an unspecified date. Patient had a double mastectomy on an unspecified date and total of 29 lymph nodes removed through all that. The patient's concomitant medications were not reported. Patient had a little bit of redness where the band aid touched her skin on 25Feb2021. The next day, on 26Feb2021, patient had a tiny red spot right where the injection was. Then the redness was gone and the tiny bit itching started on the same day on 26Feb2021. But the itching only lasted a day or so. Patient reported that typically she use special band aids from home that don't cause her to itch, as she has been told she was allergic to the glue in band aids, but didn't bring her band aids with her when she got the shot.  She came home after getting the shot and took the band aid off. Patient recovered from "a little bit of redness where the band aid touched her skin" and "tiny bit of itching" on an unspecified date, while unknown outcome for tiny red spot right where the injection.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.